Position in INCY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$30,602,212
+$9,179,371 QoQ
Shares Held
269,956
+18.6% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#86
of 855 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,119,129,230 across 124 Biotechnology names. INCY ranks #10 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,602,212 | 269,956 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $21,422,841 | 227,612 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $24,780,899 | 250,895 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $10,302,633 | 121,479 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,395,396 | 152,649 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $12,540,389 | 207,108 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $26,112,604 | 378,060 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,533,832 | 310,648 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,506,872 | 371,278 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $12,340,556 | 216,615 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $12,204,555 | 194,371 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,625,520 | 183,928 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $10,180,302 | 163,539 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,669,436 | 119,959 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,938,411 | 111,285 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,594,028 | 83,944 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,852,038 | 90,194 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,661,567 | 96,469 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $8,893,437 | 121,164 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,441,117 | 79,109 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,861,757 | 69,675 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,620,172 | 44,545 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,689,586 | 19,425 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,493,425 | 27,785 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,313,523 | 31,870 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,347,021 | 32,050 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||